Purchase Order 75N93021P00013

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company, through its BD Biosciences division, for service contract work on laboratory equipment on April 1, 2023, with a ceiling value of $236,470.02. The order is firm fixed price with no set-aside applied. Performance takes place in North Bethesda, Maryland. The ultimate completion date is March 31, 2024.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) valued at $497,331.25 on August 13, 2018, for maintenance of BD equipment. Performance is located in Franklin Lakes, New Jersey. The order covers maintenance services for BD-manufactured biomedical research instruments and diagnostic equipment. The ultimate completion date is September 14, 2018. Pricing is firm fixed price with no small business...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for BD cytometers and lasers valued at $34,936.89 on April 16, 2018, with completion on January 20, 2019. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company on September 12, 2018, with a ceiling value of $195,435.87 and an ultimate completion date of March 29, 2019. The contract is firm fixed price with no set-aside used. Place of performance is San Jose, California. The originating pre-solicitation opportunity was posted August 28, 2018, with a due date of September 6, 2018.</p>

Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $68,892.18 on January 17, 2019, for service on BD LSR II flow cytometers and lasers, covering both base year and option year 1 periods with a ceiling value matching the award amount and ultimate completion date of September 30, 2020. Performance takes place in North Bethesda, Maryland. The order is firm fixed price with no small business set-aside. The originating...

This $19,713 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Becton, Dickinson and Company's IDS division, operating as BD Diagnostic Systems. The award is for the provision of 90 BD antibodies, a commercial item. The contract has no set-aside designation and is scheduled for completion on July 22, 2016. Becton, Dickinson is a major manufacturer of medical...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company for $557,899.92 on January 17, 2019, covering service and maintenance for twelve flow cytometers and twenty-nine lasers under firm fixed price. Work is performed at North Bethesda, Maryland. The order's ultimate completion date is January 20, 2021. The solicitation was posted December 21, 2018, with award following a January 2, 2019 proposal deadline.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Becton, Dickinson And Company (BD Biosciences) on August 11, 2014, with a ceiling value of $342,273.70. This is a firm fixed price delivery order with no set-aside. Place of performance is San Jose, CA 95131. The ultimate completion date is August 22, 2018. The order references multiple AMBIS numbers (1678440, 1683429, 1683290, 1685323, 1688568) and quote numbers associated with flow cytometry instruments,...

This purchase order, awarded on September 24, 2021, to Becton, Dickinson and Company's Infectious Disease Systems division, represents an administrative de-obligation of unexpended and expiring Fiscal Year 2021 funding in accordance with 31 U.S.C. Section 1552(a). The contract, valued at $44,756.79 with a firm fixed price structure, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) and ultimately completed on September 23, 2022. The work was performed in Sparks,...